a double blind placebo-controlled randomised crossover study was performed with pentoxifylline ( trental 400 tablets with 400 mg active ingredient ) in 24 patients ( 19 males , 5 females , aged between 40 and 71 years ) suffering from peripheral occlusive arteriopathy of stage ii severity ( fontaine 's classification ) .
C0030899
pentoxifylline
C0699487
trental